News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
119 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17844)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
Kura Oncology Lead Candidate Tipifarnib Shows Durable Anti-Tumor Activity in HRAS Mutant Head and Neck Cancer
Four out of six evaluable HRAS mutant HNSCC patients enrolled in the study achieved a confirmed partial response.
October 27, 2017
·
5 min read
Policy
Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute
Eagle submitted, and the FDA accepted for filing, its NDA under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act for PEMFEXY ready-to-dilute in December 2016.
October 27, 2017
·
4 min read
BOC Sciences Added an Exclusive Section for Stem Cell Molecules
As the leading chemical supplier in the biochemical and pharmaceutical industry, on October 25, 2017, BOC Sciences announced to add an exclusive section for stem cell molecules into its product lines.
October 27, 2017
·
2 min read
Pharm Country
CRF Health’s TrialMax Touch Solution Selected for Landmark Global Oncology Study
The three year study marks CRF Health’s involvement in over 115 oncology studies which have realized the benefits of electronically collected eCOA data, and aims to better understand patients’ quality of life post-treatment.
October 27, 2017
·
2 min read
Genetown
PerkinElmer Board Declares Quarterly Dividend on October 27
This dividend is payable on February 9, 2018 to all shareholders of record at the close of business on January 19, 2018.
October 27, 2017
·
1 min read
MTPConnect Announces $7.3M in Funding for 20 National MTP Projects
MTPConnect today announced it will provide $7.35M of funding over two years for 20 national projects in the medtech, biotech and pharma sector.
October 27, 2017
·
10 min read
IBN Release: Singapore Researchers Create New ‘Alphabets’ to Enhance DNA Functions
Just like how alphabets are strung together to form words, our DNA is also strung together by alphabets to encode proteins.
October 27, 2017
·
4 min read
Medigene Participates at Six Conferences in November
Prof. Dolores Schendel, CEO and CSO of Medigene, takes part in the discussion rounds of the “Immuno-Oncology"-Forum on 13 November and will hold a company presentation on 14 November at 12.15 pm.
October 27, 2017
·
2 min read
BioForest
Physio-Control Launches Voluntary Field Action for Specific Production Lots of Infant/Child Reduced Energy Defibrillation Electrodes Produced by Cardinal Health
There is no issue with the performance or function of the defibrillation electrodes; this is limited to incorrect artwork on the defibrillation electrodes within the packaging.
October 27, 2017
·
3 min read
Business
Helix BioPharma Corp. Announces Fiscal 2017 Year-End Results and Provides Research and Development Program Update
Helix BioPharma announced its financial results for the year ended July 31, 2017 and an update on the Company’s research and development programs.
October 27, 2017
·
17 min read
Previous
3 of 12
Next